Sigyn Therapeutics (SIGY) Current Leases (2021 - 2025)
Sigyn Therapeutics (SIGY) posted Current Leases of $72300.0 for Q1 2025, up 3.37% sequentially from $69946.0 in Q4 2024, and up 14.33% YoY from $63237.0 in Q1 2024.
Sigyn Therapeutics (SIGY) Current Leases (2021 - 2025) Analysis & Trends
Sigyn Therapeutics has reported Current Leases for 5 years, with the latest figure at $72300.0 in Q1 2025.
- Quarterly Current Leases rose 14.33% year-over-year to $72300.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $72300.0 (up 14.33% YoY) and the FY2024 annual result came in at $69946.0, up 14.43% from the prior year.
- Current Leases advanced to $72300.0 in Q1 2025 per SIGY's latest filing, from $69946.0 in the prior quarter.
- Over five years, Current Leases peaked at $72300.0 in Q1 2025 and troughed at $25515.0 in Q2 2021.
- A 5-year average of $55180.9 and a median of $56074.0 in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2025: Current Leases jumped 94.18% in 2022, then increased 14.33% in 2025.
- Over 5 years, Current Leases stood at $46091.0 in 2021, then grew by 15.42% to $53200.0 in 2022, then rose by 14.89% to $61123.0 in 2023, then grew by 14.43% to $69946.0 in 2024, then gained by 3.37% to $72300.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $72300.0, $69946.0, and $67650.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 72,300.00 |
| Dec 31, 2024 | 69,946.00 |
| Sep 30, 2024 | 67,650.00 |
| Jun 30, 2024 | 65,409.00 |
| Mar 31, 2024 | 63,237.00 |
| Dec 31, 2023 | 61,123.00 |
| Sep 30, 2023 | 59,061.00 |
| Jun 30, 2023 | 57,049.00 |
| Mar 31, 2023 | 55,099.00 |
| Dec 31, 2022 | 53,200.00 |
| Sep 30, 2022 | 51,351.00 |
| Jun 30, 2022 | 49,545.00 |
| Mar 31, 2022 | 47,794.00 |
| Dec 31, 2021 | 46,091.00 |
| Sep 30, 2021 | 38,524.00 |
| Jun 30, 2021 | 25,515.00 |